Getinge AB Class B · OMXSTO:GETI_B
Getinge AB Class B — Q2 2002 Earnings Presentation
16 slides from Getinge AB Class B's earnings presentation, 2002
Slide 1: GETINGE
GETINGE An expanding Medical-Technology group with Focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people Customers Acute care Long term care Industry / Laboratories Net Sales 8.1 billion SEK Associates 5 300 Manufacturing I8 production units
Slide 2: Getinge Group Objectives
Getinge Group Objectives Strategic To develop world leading positions in prioritized niches of the health care industry
Slide 3: Getinge Group Objectives
Getinge Group Objectives Strategic To develop world leading positions in prioritized niches of the health care industry Financial To increase profit before tax with an average of I5% per annum Internally generated cash flow to sustain an external growth rate of I0% per annum
Slide 4: Business Area Extended Care
Business Area Extended Care Hygiene Patient Handling Wound Care Systems Complete solutions for institutional extended care: Nursing homes, Hospitals, Assisted Living
Slide 5: Extended Care
Extended Care Market development Q 2 (msek) 2002 2001 Change 2002 2001 Change per market Q2 Q2 6 Mon 6 Mon USA and Canada 237 237 0% 486 477 2% Great Britain 156 138 13% 357 344 4% Germany 75 68 10% 147 136 8% Other W Europe 156 151 3% 309 312 -1% Rest of the world 31 22 40% 51 42 20% Business area
Slide 6: Extended Care
Extended Care Results Q 2 (msek) 2002 2001 2002 2001 2001 Q2 Q 2 6 Mon 6 Mon FY Net sales 649 629 1,341 1,293 2,656 Gross margin % 48.0% 48.6% 50.6% 48.8% 49.2% Operating cost -219 227 -459 437 -886 Operating profit 93 79 219 193 421 Operating margin % 14.2% 12.5% 16.3% 15.0% 15.9%
Slide 7: Business Area Infection Control
Business Area Infection Control Health Care Disinfection SterilizationIT-Solutions Load Handling Complete systems for: Central Processing Departments, Outpatient Surgery, Wards, Infectious Waste, Microbiology, Pharmacies
Slide 8: Business Area Infection Control
Business Area Infection Control Industry Sterilization Washing Water Load Handling Treatment Complete systems for: Production, Research/Laboratories, Animal Care Facilities, Food Industry
Slide 9: Infection Control
Infection Control Market development Q 2 (msek) 2002 2001 Change 2002 2001 Change per market Q2 Q2 6 Mon 6 Mon Western Europe 401 374 7% 776 719 8% USA and Canada 425 344 23% 750 643 17% Asia/Australia 112 86 31% 179 149 20% Rest of the world 46 41 13% 82 66 26% Business area total 984 845 17% 1 787
Slide 10: Infection Control
Infection Control Results Q 2 (msek) 2002 2001 2002 2001 2001 Q2 Q 2 6 Mon 6 Mon FY Net sales 854 749 1,543 1,431 3,204 Gross margin % 34.7% 36.6% 35.6% 36.1% 36.0% Operating cost -246 -210 -468 -402 -833 Operating profit 51 64 81 115 321 Operating margin % 5.9% 8.5% 5.3% 8.0% 10.0%
Slide 11: Business Area Surgical Systems
Business Area Surgical Systems Surgical Surgical Lights Ceiling Service Tables Systems Integrated solutions for: Surgical Workstations and ICU’s
Slide 12: Surgical Systems
Surgical Systems Market development Q 2 (msek) 2002 2001 Change 2002 2001 Change per market Q2 Q2 6 Mon 6 Mon USA and Canada 115 107 8% 227 206 10% Great Britain 25 19.1 30% 80 65.3 22% Germany 110 166.5 -34% 247 315.5 -22% Other W Europe 172 214 -19% 341 339.9 0% Rest of the world 119 134 -11% 306
Slide 13: Surgical Systems
Surgical Systems Results Q 2 (msek) 2002 2001 2002 2001 2001 Q2 Q 2 6 Mon 6 Mon FY Net sales 566 534 1,084 1,090 2,223 Gross margin % 50.6% 50.5% 48.4% 49.1% 49.9% Operating cost -208 -207 -413 -412 -881 Operating profit 79 63 111 123 228 Operating margin % 13.9% 11.7% 10.3% 11.3% 10.3%
Slide 14: Group Focus 2002 - 2004
Group Focus 2002 - 2004 Infection Control To create a customer focused group from a federation of companies acquired over the last I0 years Extended Care Focus on growth from a solid platform through product innovation, Market penetration and geographical expansion Surgical Systems To create a globa
Slide 15: Getinge AB
Getinge AB Results (msek) 2002 2001 Change 2002 2001 Change 2001 Q2 Q2 6 Mon 6 Mon FY Orders received 2,188 2,114 4% 4,356 4,100 6% 8,376 Net sales 2,078 1,926 8% 3,987 3,845 4% 8,148 EBITDA 320 297 8% 605 612 -1% 1,341 Operating profit 223 206 8% 412 434 -5% 974 Operating margin 10.7% 10.7% 10.3% 1
Slide 16: Getinge AB
Getinge AB Balance sheets (msek) Assets 2002-06-30 2001-06-30 2001-12-31 Fixed assets 4,340 4,509 4,572 Current assets 4,691 4,857 5,018 Total assets 9,031 9,366 9,589 Shareholders' equity & liabilities Shareholders' equity 2,785 2,643 2,953 Provisions 1,665 1,826 1,778 Long-term liabilities 3,017 2